This study is for an inhaled nebulized combination (FDC) suspension as a novel therapy for the maintenance treatment
of chronic obstructive pulmonary disease (COPD). Study will last approximately one month long with 7 office visits to the clinic. Pulmonary function tests will be required. Medication will be provided as well as rescue albuterol.
Compensation provided up to $1800 for completing all the required visits.